Overview of key QQ2 2025 metrics (EUR unless stated):
- Revenue: 130,181,652; YoY +92.99%; QoQ +100.00% (per dataset; note: quarterly data shows Q1 and Q2 2025 revenue of EUR 130,181,652 each, implying potential staged recognition within a year-to-date framework).
- Gross Profit: 35,609,898; Gross Margin 27.35%; YoY +93.85%; QoQ +100.00%.
- EBITDA: 4,815,829; EBITDA Margin 3.70%.
- Operating Income: 14,302; Operating Margin 0.01% (very low leverage on revenue).
- Net Income: -282,830; Net Margin -0.22%; YoY -117.38%; QoQ -100.00%.
- EPS: -0.01; Diluted EPS: -0.01; Weighted Shares: 28.283 million.
- Cash Flow: Operating cash flow -4,531,000; Capex -2,699,500; Free cash flow -7,230,499.
- Balance Sheet (EUR): Cash and cash equivalents 86,504,060; Total assets 1,083,048,471; Total liabilities 762,050,062; Total equity 310,585,823.
- Leverage & Liquidity: Short-term debt 3,027,383; Long-term debt 8,213,651; Total debt 11,241,034; Net debt -75,263,026 (net cash).
- Working Capital & Efficiencies: Current ratio 0.83; Quick ratio 0.61; Cash ratio 0.12; DSO 64.24 days; DIO 72.26 days; DPO 42.02 days; CCC 94.48 days.
- Historical context: Four-quarter sequence indicates stability in Q1–Q2 2025 revenue around EUR 130.18m and higher previous-year revenues in late 2024 (Q3/Q4) at approximately EUR 134.91m, suggesting a normalization around the EUR 130–135m quarterly band.